To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Mouse mammary tumor virus
Mouse mammary tumor virus (MMTV) is a milk transmitted retrovirus like the HTL viruses, HI viruses and BLV. It belongs to the genus betaretroviruses. MMTV was formerly known as Bittner virus, and previously the 'milk factor' referring to the extra-chromosomal vertical transmission of murine breast cancer by adoptive nursing, demonstrated by Dr. John J. Bittner. The majority of mammary tumors in mice are caused by Mouse Mammary Tumour Virus (MMTV).
Additional recommended knowledge
Infection and life Cycle
Several mouse strains carry the virus endogenously, but it is also transmitted vertically via milk from mother to pup. It is contained as a DNA provirus integrated in the DNA of milk lymphocytes. The viruses become transported through the gastrointestinal tract to the Peyer's patches where they infect the new host's macrophages, and then lymphocytes.
The Mouse Mammary Tumor Virus (MMTV) has formerly been classified as a simple retrovirus, however, it has recently been established, that MMTV encodes an extra self-regulatory mRNA export protein, Rem, with resemblance to the Human Immunodeficiency Virus HIV Rev protein, and is therefore the first complex murine retrovirus to be documented
MMTV codes for the retroviral structural genes and additionally for a superantigen. This stimulates T lymphocytes with a certain type of V beta chain in their T cell receptor, which in turn stimulates B cell proliferation increasing the population of cells that can be infected. During puberty, the virus enters the mammmary glands with migrating lymphocytes and infects proliferating mammary gland epithelial cells.
When the virus genome is inserted inside the host genome it is then able to transcribe its own viral genes. In F. U. Reuss and J. M. Coffin (2000) experiments it is mentioned that the expression of the virus genome is activated by an enhancer element that is present in the U3 region of the long terminal repeat of the genome . In addition the expression of the genome is activated specifically in the mammary gland cells . Estrogen is able to further activate the expression of the viral genome . The expression of sag gene which is present in the provirus is responsible for the production of a superantigen.
MMTV can be transferred either through an exogenous or endogenous route. If the virus is transferred exogenously, it is passed from the mother mouse to her pups through her milk. 
Alternatively, pups can be infected vertically through endogenous infection, inheriting the virus directly from their mother in the germline. Mice that become infected in this way have higher rates of occurrence of tumors. A retrovirus is endogenous to its host once the proviral DNA is inserted in to the chromosomal DNA. As a result mice with endogenous MMTV have the virus’s DNA in every cell of its body, as the virus is present in the DNA of the sperm or egg cell from which the animal is conceived.
Hormonal responisveness of integrated MMTV DNA
Endogenous MMTV responds to estrogen, so when the mouse reaches puberty the virus begins to express its messenger RNA in the estrogen sensitive tissues. As a result, after puberty all mammary cells will contain the active retrovirus and being to replicate in the genome and express viral messenger RNA is all new mammary tissue cells.  The strongest hormone for virus production is the artificial cortison dexamethasone. Dexamethasone is a strong inducer of lactation and is used for this purpose in the dairy industry.
MMTV and human breast cancer
As the infected mice develop mammary tumors in adulthood, MMTV has inspired the search for a human breast cancer virus. While the tumors caused by MMTV are benign and in general do not metastasize in mice. Especially they do not metastasize to the bones as it is typical for human breast cancer and also for the acute leukemia caused by HTLV-I. That makes the virus not useful as a model for human breast cancer, a malignant disease.
MMTV has been found in human breast cancer. A complete proviral sequence that was greater than 95% homologous to MMTV was sequenced out of human breast cancer tissue including a correct integration into the human genome. It was named Human Mammary Tumor Virus (HMTV). Early indications of MMTV (or MMTV like) virus involvement were confused by the presence of Human Endogenous RetroVirus (HERV) sequences that have a much lower level of homology to MMTV than HMTV. These were traces of one or more viruses similar to MMTV. It is emerging that many human breast cancers contain part of the env gene of a virus that is very close to MMTV. The presence of HMTV (not HERV) sequences has been found by multiple researchers in up to 42% of breast cancers in Europe, North America as well as Australia. This is compared to only 1 to 2% of the healthy population. While some consider the presence of MMTV in humans controversial, there is a large amount of evidence that MMTV (or a VERY close relative) plays a role in some human breast cancers. The env gene sequences are not found in the other cells of the body suggesting that they are of foreign origin. That being said, Garry, Pogo, and Holland all have patented the use of MTV sequences for diagnostic uses in detection of human breast cancer (Pat #’s 6,670,466; 6,040,146; 5,686,247 respectively). Dr. Garry also claims that there is an endogenous version of HMTV in up to 14% of the population in his patent though he has yet to publish a peer reviewed article demonstrating his evidence.
MMTV has also been implicated in other human diseases. In the mouse, MMTV can also cause leukemia. Human breast cancer has been correlated with leukemia in humans and viral sequence has been found in these cancers. A complete proviral sequence has also been sequenced for the lymph nodes of patients with Primary Biliary Cirrhosis. Biliary epithelial cells infected with MMTV convert to the same pathology as those found in PBC patients.
MMTV is an interesting virus for human diseases. It has superantigenic properties which destroy part of the immune system of the infected mouse. The well documented MMTV pathogenesis helps to understand the action of superantigens in human disease.
In the last few years a number of labs have found MMTV like DNA in human breast cancer tissue and most recently, the virus has been shown to be able to productively infect human cells, possibly suggesting that an MMTV like virus may play a role in human breast cancer. It was shown too, that human breast cancer often occurs in areas where Mus domesticus is the prominent species of mice. In the lab, MMTV was shown to readily infect canine and feline tissue culture cells. One theory of how MMTV would be passed to humans is through contact with our pets. All though it is difficult to imagine how modern women would get infected by a mouse virus, an infection of both species by the same food might be a possibility, or passage from one species to the other may also occur. This mode of infection might explain the often seen development of benign or malignant mammary tumors in pets. Dogs and cats are often affected and they too have access to human food and share living space with humans.
The MMTV promotor in models of human breast cancer
The LTR (long terminal repeat) of MMTV contains a glucocorticoid hormone response element. This glucocorticoid element is a promotor that is often used to construct mice which develop a breast cancer-like disease, because an animal model system for breast cancer close to the human disease is very much looked for.
The MMTV promotor is used in the PYMT model system of breast cancer. Here PY is the abbreviation of polyoma middle T-antigen and MT is the abbrevation for the MMTV promotor. There are more model systems of breast cancer which use the MMTV promotor. The polyoma middle T-antigen is taken from the polyoma virus. In human breast cancer the polyoma middle T- antigen was not found.
Recent scientific publications
References . F. U. Reuss and J. M. Coffin. (2000). The Mouse Mammary Tumor Virus Transcription Enhancers for Hematopoietic Progenitor and Mammary Gland Cells Share Functional Elements. Journal of Virology, p. 8183-8187
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Mouse_mammary_tumor_virus". A list of authors is available in Wikipedia.|